Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
about
Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon.New treatment options for lower respiratory tract infections.Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?Sex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite).Role of the N-acetylation polymorphism in solithromycin metabolism.
P2860
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@en
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@nl
type
label
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@en
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@nl
prefLabel
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@en
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@nl
P2093
P2860
P50
P1433
P1476
Solithromycin: A Novel Fluorok ...... -Acquired Bacterial Pneumonia.
@en
P2093
Alfred S Gin
Andrew J Walkty
Bala Gorityala
Daryl J Hoban
Erika Hartel
Frank Schweizer
Heather Adam
James A Karlowsky
Joseph P Lynch
Michael A Zhanel
P2860
P2888
P304
P356
10.1007/S40265-016-0667-Z
P577
2016-12-01T00:00:00Z